Resources | NITAG RESOURCE CENTER

2024 ∙ STIKO

Resolution on the STIKO recommendation for a standard vaccination against diseases caused by respiratory syncytial viruses (RSV) for persons ≥ 75 years of age and for the indication vaccination of persons aged 60 to 74 years with risk factors

2024 ∙ STIKO

Modelling methods for predicting epidemiological and health economic effects of vaccinations. Guidance for analyses to be presented to the German Standing Committee on Vaccination (STIKO)

2024 ∙ STIKO

The STIKO recommendation on vaccination against dengue with the Qdenga vaccine

2023 ∙ Lanza, T. E. Lombardi, G. S. Tumelero, S. Paladini, A. Castagna, C. Cadeddu, C.

Barriers and strength factors of adult immunization plans in seven countries of the European region

2023 ∙ Babatope, T. Ilyenkova, V. Marais, D.

COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria

2023 ∙ STIKO

Decision on the implementation of the COVID-19 vaccination into the general recommendations of the STIKO 2023

2023 ∙ STIKO

Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023

2023

Updated HPV Technical Dossier on Quadrivalent HPV (Gardasil-4valent) 1-dose Regimen

2022 ∙ Olu-Abiodun, O. Abiodun, O. Okafor, N.

COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors

2022 ∙ Sabine Vygen-Bonnet, Johanna Schlaberg, Judith Koch

Role, working methods and recommendations of the Standing Committee on Vaccinations (STIKO) in the context of the COVID-19 pandemic